Drug for Treatment of Diabetes

User Rating: 5 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Active


Launching of newer drug for treatment of Diabetes at Berhampur 


Berhampur dated 6th May 2016: Seven crore Indian people are suffering from Diabetes. The existing set of oral antidiabetic drugs help to control sugars in the initial phase. To bring down the rising blood sugars, there are several newer drugs being scientifically developed. An academic meeting was held yesterday to launch one such newer drug Empagliflozin for the first time in Berhampur. Dr Sunil Kumar Kota, Consultant Endocrinologist from Diabetes & Endocare Clinic, Berhampur was the chief speaker for the event, chaired by Prof Dr Lalit Kumar Meher, Head of the Dept, Gen Medicine, MKCG Medical College. Dr Kota highlighted the usage pattern, efiicacy and safety profile this of drug to the audience.


 SGLT2 receptors are located in the kidney tubules, help in entry of glucose from urine into blood. Empagliflozin blocks these SGLT2 receptors and prevents absorption of glucose into blood leading to excretion of around 80 grams glucose through urine per day. It reduces blood glucose even in long standing diabetics, where other drugs tend to fail. It has additional advantages of reduction of body weight, blood pressure and cholesterol, avoidance of hypoglycaemia. Recent scientific study EMPAREG has demonstrated significant reduction of cardiovascular complications and mortality in patients taking Empagliflozin in addition to improvement in kidney health and reduction of insulin requirement for diabetes treatment. Empagliflozin was launched in America in May 2014 followed by in India in Nov 2015. 


Total of around 50 doctors from MKCG Medical college and private practitioners of Berhampur attended the session. Renowned doctors like Prof P C Sahoo, Prof Prabin Rath also graced the occasion. Dr Sunil Kota concluded the session by question and answer on Empagliflozin, with the audience.

1ST Floor, Mahapatro Building
Telephone Bhaban Road
Contact- +919437298989
This Week
Last Week
This Month
Last Month
All days

Your IP:
2018-02-22 17:53